TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
Erazo, Tatiana, Evans, Chiara M., Zakheim, Daniel, Chu, Eren L., Refermat, Alice Yunsi, Asgari, Zahra, Yang, Xuejing, Da Silva Ferreira, Mariana, Mehta, Sanjoy, Russo, Marco Vincenzo, Knezevic, Andrea, Zhang, Xi-Ping, Chen, Zhengming, Fennell, Myles, Garippa, Ralph, Seshan, Venkatraman, de Stanchina, Elisa, Barbash, Olena, Batlevi, Connie Lee, Leslie, Christina S., Melnick, Ari M., Younes, Anas, Kharas, Michael G.
Published in Nature communications (27.09.2022)
Published in Nature communications (27.09.2022)
Get full text
Journal Article
TP53 Mutations and RNA Binding Protein Musashi 2 Drive Resistance to PRMT5-Targeted Therapy in B-Cell Lymphoma
Erazo, Ingrid Tatiana, Evans, Chiara M, Zakheim, Daniel, Chu, Karen L, Barbash, Olena, Refermat, Alice Yunsi, Batlevi, Connie Lee, Younes, Anas, Kharas, Michael G
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article